A Blood Pressure Drug’s Surprising Shield for the Brain
A large cohort study has found that among hypertensive patients on long-term renin-angiotensin system inhibitor therapy, those prescribed telmisartan had a lower risk of developing dementia and stroke compared to those on other drugs in the same class. The research, tracking nearly 40,000 patients, suggests telmisartan may offer marginally better protection for cognitive and cerebrovascular health, independent of blood sugar levels.
Why it might matter to you:
This work highlights how existing, approved drugs can be repurposed for neuroprotection, a key strategy in neurodegenerative disease. For a researcher focused on actionable biomarkers, it underscores the need to consider systemic cardiovascular factors and their treatments as critical variables when correlating blood-based proteomic signals with disease progression and clinical outcomes.
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
